Actively Recruiting
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
Led by Boehringer Ingelheim · Updated on 2026-05-07
312
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
Sponsors
B
Boehringer Ingelheim
Lead Sponsor
T
TIC Social Mexico
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to characterize the epidemiology of interstitial lung diseases (ILD) associated to connective tissue disease (CTD) in Mexico, and to study its correlation with the different comorbidities and treatments used, as well as the possible impacts of these factors on the outcome of progression, exacerbations, and mortality in patients with ILD associated to CTD.
CONDITIONS
Official Title
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients
- Age 18 years or older
- Signed informed consent to use medical information
- Diagnosed with rheumatoid arthritis, connective tissue diseases (including systemic sclerosis, inflammatory myopathies, systemic lupus erythematosus, primary Sj�f6gren syndrome, pulmonary fibrosis with non-specific autoimmunity, systemic vasculitis, psoriasis, ankylosing spondylitis, reactive arthritis), spondyloarthritis, or sarcoidosis
- Diagnosed with interstitial lung disease confirmed clinically and by high-resolution computed tomography with an interstitial pattern
- For existing data: medical records from patients lost to follow-up since 2012 with required diagnostic information
You will not qualify if you...
- Biopsy-confirmed usual interstitial pneumonitis not related to connective tissue disease
- Pneumonitis caused by chemotherapy or radiotherapy
- Medical records lacking full diagnosis of interstitial lung disease by clinical criteria and biopsy or high-resolution computed tomography
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Colegio Mexicano de Reumatologia
Mexico City, Mexico, 04318
Actively Recruiting
Research Team
B
Boehringer Ingelheim
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here